Matches in Wikidata for { <http://www.wikidata.org/entity/Q91037313> ?p ?o ?g. }
Showing items 1 to 75 of
75
with 100 items per page.
- Q91037313 description "article scientifique publié en 2019" @default.
- Q91037313 description "artículu científicu espublizáu n'ochobre de 2019" @default.
- Q91037313 description "im Oktober 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q91037313 description "scientific article published on 30 October 2019" @default.
- Q91037313 description "wetenschappelijk artikel" @default.
- Q91037313 description "наукова стаття, опублікована 30 жовтня 2019" @default.
- Q91037313 name "Overview of Immune Checkpoint Inhibitors Therapy for Hepatocellular Carcinoma, and The ITA.LI.CA Cohort Derived Estimate of Amenability Rate to Immune Checkpoint Inhibitors in Clinical Practice" @default.
- Q91037313 name "Overview of Immune Checkpoint Inhibitors Therapy for Hepatocellular Carcinoma, and The ITA.LI.CA Cohort Derived Estimate of Amenability Rate to Immune Checkpoint Inhibitors in Clinical Practice" @default.
- Q91037313 type Item @default.
- Q91037313 label "Overview of Immune Checkpoint Inhibitors Therapy for Hepatocellular Carcinoma, and The ITA.LI.CA Cohort Derived Estimate of Amenability Rate to Immune Checkpoint Inhibitors in Clinical Practice" @default.
- Q91037313 label "Overview of Immune Checkpoint Inhibitors Therapy for Hepatocellular Carcinoma, and The ITA.LI.CA Cohort Derived Estimate of Amenability Rate to Immune Checkpoint Inhibitors in Clinical Practice" @default.
- Q91037313 prefLabel "Overview of Immune Checkpoint Inhibitors Therapy for Hepatocellular Carcinoma, and The ITA.LI.CA Cohort Derived Estimate of Amenability Rate to Immune Checkpoint Inhibitors in Clinical Practice" @default.
- Q91037313 prefLabel "Overview of Immune Checkpoint Inhibitors Therapy for Hepatocellular Carcinoma, and The ITA.LI.CA Cohort Derived Estimate of Amenability Rate to Immune Checkpoint Inhibitors in Clinical Practice" @default.
- Q91037313 P1433 Q91037313-008364D6-969A-456D-99E0-7EBE13177010 @default.
- Q91037313 P1476 Q91037313-08CBCDAE-D52D-47F3-A0CF-34BA1B564D88 @default.
- Q91037313 P2093 Q91037313-000A9DAB-406F-49F8-8725-EE726A7B77A4 @default.
- Q91037313 P2093 Q91037313-0862751E-3936-431F-915D-0ABE74E9EE6D @default.
- Q91037313 P2093 Q91037313-15505700-D0CE-4238-AD7D-211B0F1ED057 @default.
- Q91037313 P2093 Q91037313-1B65F2FC-7ADA-44D3-A407-E12332BCECF9 @default.
- Q91037313 P2093 Q91037313-50EB9210-8F43-4BAF-8881-88DA613095FA @default.
- Q91037313 P2093 Q91037313-51EBBF73-26ED-423B-9BA1-996928688BD7 @default.
- Q91037313 P2093 Q91037313-5C7723E7-1EC6-4504-A2B5-5B98662D794B @default.
- Q91037313 P2093 Q91037313-678F98CC-8B56-4C35-B9C0-2A6FF34EB978 @default.
- Q91037313 P2093 Q91037313-79DA008F-1AC4-4CA9-9EDF-4EB3043F32BC @default.
- Q91037313 P2093 Q91037313-A152A4BB-A1A0-448A-8FE6-A19E65B5F734 @default.
- Q91037313 P2093 Q91037313-B1A2C214-2967-42A3-8E18-95BF09562A0F @default.
- Q91037313 P2093 Q91037313-C8652D35-288B-45F4-9C5F-8E26ECFCE3F9 @default.
- Q91037313 P275 Q91037313-048725af-9042-4a39-a686-081306612957 @default.
- Q91037313 P31 Q91037313-4719013D-7BDD-43A8-9D72-FF94A3095B1D @default.
- Q91037313 P31 Q91037313-d772b46e-761c-4344-b30e-258fa1a704c8 @default.
- Q91037313 P356 Q91037313-2D37848C-5ACE-4070-BFAF-296CB91DD7B5 @default.
- Q91037313 P433 Q91037313-E707ECD1-DBAF-4589-9E99-4EC006863283 @default.
- Q91037313 P478 Q91037313-E74A8758-8959-485E-B470-7BEFF6D1C237 @default.
- Q91037313 P50 Q91037313-1F86E696-392D-4493-9133-7225C84DBC4E @default.
- Q91037313 P50 Q91037313-2E7FC463-1649-4E3A-A76A-B6C1C0BAE64F @default.
- Q91037313 P50 Q91037313-D0F71C9F-75D1-465C-BEAB-5161944DF3D4 @default.
- Q91037313 P50 Q91037313-D1010C96-8B07-421C-87C0-A08517E14AA6 @default.
- Q91037313 P50 Q91037313-D7C3C7C3-FE0B-4A55-98FF-096DD3ABDEEA @default.
- Q91037313 P50 Q91037313-EFE03BE0-570D-4BF6-9048-0380CBCF1C89 @default.
- Q91037313 P577 Q91037313-06B8F7A5-1699-4D3C-A93E-2AB1BEA4E7B3 @default.
- Q91037313 P6216 Q91037313-8d752163-77ab-476c-bc26-26ba05b41dce @default.
- Q91037313 P698 Q91037313-7A3BC464-BC80-40AB-99CE-285C7CBB0503 @default.
- Q91037313 P932 Q91037313-64D172BA-E472-47F6-8503-C3397CDDE8D6 @default.
- Q91037313 P356 CANCERS11111689 @default.
- Q91037313 P698 31671581 @default.
- Q91037313 P1433 Q27722963 @default.
- Q91037313 P1476 "Overview of Immune Checkpoint Inhibitors Therapy for Hepatocellular Carcinoma, and The ITA.LI.CA Cohort Derived Estimate of Amenability Rate to Immune Checkpoint Inhibitors in Clinical Practice" @default.
- Q91037313 P2093 "Alessandro Vitale" @default.
- Q91037313 P2093 "Andrea Aglitti" @default.
- Q91037313 P2093 "Associazione Italiana per lo Studio del Fegato (AISF) HCC Special Interest Group" @default.
- Q91037313 P2093 "Fabio Melandro" @default.
- Q91037313 P2093 "Filomena Morisco" @default.
- Q91037313 P2093 "Francesca Romana Ponziani" @default.
- Q91037313 P2093 "Franco Trevisani" @default.
- Q91037313 P2093 "Maria Rendina" @default.
- Q91037313 P2093 "Martina Gambato" @default.
- Q91037313 P2093 "Mauro Borzio" @default.
- Q91037313 P2093 "Mauro Viganò" @default.
- Q91037313 P2093 "Rodolfo Sacco" @default.
- Q91037313 P275 Q20007257 @default.
- Q91037313 P31 Q13442814 @default.
- Q91037313 P31 Q7318358 @default.
- Q91037313 P356 "10.3390/CANCERS11111689" @default.
- Q91037313 P433 "11" @default.
- Q91037313 P478 "11" @default.
- Q91037313 P50 Q41633423 @default.
- Q91037313 P50 Q41822939 @default.
- Q91037313 P50 Q56850282 @default.
- Q91037313 P50 Q56959494 @default.
- Q91037313 P50 Q56970781 @default.
- Q91037313 P50 Q84629605 @default.
- Q91037313 P577 "2019-10-30T00:00:00Z" @default.
- Q91037313 P6216 Q50423863 @default.
- Q91037313 P698 "31671581" @default.
- Q91037313 P932 "6896125" @default.